| Literature DB >> 24660060 |
Tarun George1, Stalin Viswanathan2, Ali Hasan Faiz Karnam1, Georgi Abraham1.
Abstract
Objectives. Etiology and outcomes of acute lung injury in tropical countries may be different from those of western nations. We describe the etiology and outcomes of illnesses causing acute lung injury in a rural populace. Study Design. A prospective observational study. Setting. Medical ICU of a teaching hospital in a rural-urban fringe location. Patients. Patients ≥13 years, admitted between December 2011 and May 2013, satisfying AECC criteria for ALI/ARDS. Results. Study had 61 patients; 46 had acute lung injury at admission. Scrub typhus was the commonest cause (7/61) and tropical infections contributed to 26% of total cases. Increasing ARDS severity was associated with older age, higher FiO2 and APACHE/SOFA scores, and longer duration of ventilation. Nonsurvivors were generally older, had shorter duration of illness, a nontropical infection, and higher total WBC counts, required longer duration of ventilation, and had other organ dysfunction and higher mean APACHE scores. The mortality rate of ARDS was 36.6% (22/61) in our study. Conclusion. Tropical infections form a major etiological component of acute lung injury in a developing country like India. Etiology and outcomes of ARDS may vary depending upon the geographic location and seasonal illnesses.Entities:
Year: 2014 PMID: 24660060 PMCID: PMC3934087 DOI: 10.1155/2014/181593
Source DB: PubMed Journal: Crit Care Res Pract ISSN: 2090-1305
Etiology and survival of patients in our study.
| Direct injury | Number of cases | Survived | Indirect injury | Number of cases | Survived |
|---|---|---|---|---|---|
| Pneumonia | Sepsis | ||||
| (1) CAP | 6 | 6 | (1) Malaria | 2 | 2 |
| (2) HAP | 8 | 3 | (2) MRSA | 3 | 1 |
| (3) H1N1 | 4 | 3 | (3) | 1 | 0 |
| (4) Leptospirosis | 2 | 1 | (4) | 1 | 0 |
| (5) Scrub typhus | 7 | 6 | (5) Unidentified | 5 | 1 |
| (6) Aspiration | 2 | 1 | Pancreatitis | 4 | 3 |
| Dengue | 3 | 3 | OP poisoning | 2 | 1 |
| Tuberculosis | 2 | 2 | Herbicide poisoning | 1 | 1 |
| Toxic inhalation | 1 | 1 | Near-hanging | 1 | 1 |
| Near-drowning | 3 | 3 | |||
| Paraquat poisoning | 3 | 0 | |||
|
| |||||
| Total | 41 | 29 | Total | 20 | 12 |
MRSA: methicillin resistant Staphylococcus aureu; E.coli: Escherichia coli; OP: organophosphate poisoning; CAP: community acquired pneumonia; VAP: ventilator associated pneumonia.
Characteristics of patients based on Berlin definition—demographics, laboratory investigations (means), complications, and hospital course.
| ARDS according to Berlin definition | Mild ( | Moderate ( | Severe ( |
|---|---|---|---|
| Age (years) | 40.83 ± 13.72 | 41.21 ± 16.03 | 54.00 ± 17.79 |
| Female sex | 9 (37.5) | 18 (54.5) | 2 (50) |
| Duration of illness (days) | 6 | 4 | 3 |
| Heart rate (beats/min) | 98.79 ± 13.28 | 115.73 ± 14.08 | 129.25 ± 9.91 |
| Mean arterial pressure (mmHg) | 90.00 ± 10.44 | 83.69 ± 15.72 | 75.83 ± 3.19 |
| pH | 7.38 ± 0.03 | 7.38 ± 0.06 | 7.19 ± 0.13 |
| pO2 (mmHg) | 87.92 ± 13.93 | 80.82 ± 24.29 | 62.50 ± 9.98 |
| HCO3 (mmol/L) | 20.25 ± 3.39 | 19.39 ± 4.76 | 11.25 ± 1.89 |
| FiO2 (%) | 42.50 ± 16.50 | 58.48 ± 17.77 | 75.00 ± 19.14 |
| ARDS at presentation | 22 (91.6) | 21 (63.6) | 3 (75) |
| Total leukocyte count (×103/L) | 10.891 ± 4.604 | 13.048 ± 6.238 | 13.475 ± 3.450 |
| Platelets (×103/L) | 176.666 ± 99.589 | 183.121 ± 109.270 | 118.000 ± 91.082 |
| ESR (mm) | 59.46 ± 27.28 | 59.94 ± 32.22 | 65.00 ± 37.00 |
| Albumin (g/dL) | 3.45 ± 0.65 | 3.39 ± 0.89 | 2.75 ± 0.50 |
| Urea (mmol/L) | 13.05 ± 4.98 | 16.50 ± 6.64 | 36.88 ± 11.20 |
| Creatinine (µmol/L) | 81.04 ± 37.65 | 126.44 ± 75.35 | 316.04 ± 132.38 |
| Glomerular filtration rate | 108.13 ± 50.62 | 69.91 ± 33.37 | 22.00 ± 9.40 |
| Glasgow coma scale (median) | 14 | 10 | 8 |
| Infectious etiology | 18 (75) | 26 (78.7) | 2 (50) |
| Tropical infections | 10 (41.6) | 5 (15.1) | 1 (25) |
| Direct lung injury | 20 (83.3) | 22 (66.6) | 3 (75) |
| APACHE II score | 6.54 ± 6.53 | 15.06 ± 8.47 | 28.00 ± 5.83 |
| SOFA score | 4.52 ± 2.52 | 7.67 ± 2.98 | 13.50 ± 1.29 |
| Mechanical ventilation | 5 (20.8) | 30 (90.9) | 4 (100) |
| Days ventilated | 1.38 ± 3.18 | 6.48 ± 4.15 | 6.75 ± 3.40 |
| Inotrope use | 5 (20.8) | 20 (60.6) | 4 (100) |
| Duration of stay (days) | 6.21 ± 2.60 | 9.67 ± 3.25 | 7.75 ± 3.30 |
| Nonsurvival | 4 (16.6) | 14 (42.4) | 4 (100) |
APACHE: acute physiology and chronic health evaluation; SOFA: sequential organ failure assessment score; ARDS: acute respiratory distress syndrome; ESR: erythrocyte sedimentation rate.
Univariate analysis of risk factors for mortality.
| Variable | Number | Relative risk | CI | Significance |
|---|---|---|---|---|
| Demographics | ||||
| Age > 50 years | 8/18 | 1.99 | 1.05–3.75 | 0.04* |
| Male sex | 12/32 | 1.08 | 0.55–2.13 | 0.50 |
| Illness duration < 1 week | 20/54 | 1.296 | 0.38–4.39 | 0.66 |
| Risk factors | ||||
| Smoking | 8/16 | 1.60 | 0.83–3.09 | 0.17 |
| Alcohol | 7/14 | 1.56 | 0.82–3.06 | 0.21 |
| Smoking + alcohol | 7/12 | 1.90 | 1.00–3.60 | 0.07* |
| Comorbidities | 14/26 | 2.35 | 1.16–4.76 | 0.013* |
| Infection | 17/46 | 1.10 | 0.49–2.49 | 0.52 |
| Prior hospitalization | 5/7 | 2.26 | 1.23–4.18 | 0.038* |
| Clinical signs | ||||
| Temperature > 100 F | 10/21 | 1.58 | 0.82–3.04 | 0.14 |
| Heart rate > 100 | 17/42 | 1.53 | 0.66–3.55 | 0.20 |
| Investigations | ||||
| pH < 7.40 | 14/37 | 1.13 | 0.56–2.28 | 0.46 |
| TLC > 11 (×103/L) | 17/33 | 2.88 | 1.22–6.88 | 0.006* |
| Thrombocytopenia < 150 (×103/L) | 9/25 | 0.99 | 0.50–1.96 | 0.99 |
| Serum albumin < 3 g/dL | 13/35 | 1.07 | 0.54–2.12 | 0.83 |
| Nontropical infection | 32/46 | 3.28 | 0.86–12.47 | 0.04* |
| Organ dysfunction | ||||
| AKI | 14/23 | 2.89 | 1.43–5.80 | 0.002* |
| Altered sensorium | 20/29 | 11.03 | 2.82–43.16 | <0.001* |
| Direct lung injury | 15/45 | 0.76 | 0.38–1.52 | 0.32 |
| ARDS | 38/61 | 1.92 | 1.34–2.75 | 0.001* |
| SGOT > 3 times elevation | 19/50 | 1.39 | 0.49–3.89 | 0.38 |
| SGPT > 3 times elevation | 20/54 | 1.29 | 0.38–4.39 | 0.50 |
| APACHE II score > 20 | 14/61 | 5.36 | 2.81–10.22 | <0.001* |
| Hospital course | ||||
| ARDS after admission | 10/15 | 2.55 | 1.39–4.67 | 0.004* |
| Ventilation > 7 days | 11/17 | 2.58 | 1.39–4.81 | 0.005* |
| Inotrope use | 20/29 | 11.03 | 2.81–43.16 | <0.001* |
| CPR | 18/19 | 17.19 | 2.54–116.11 | <0.001* |
TLC: total leukocyte count; AKI: acute kidney injury; ARDS: acute respiratory distress syndrome; SOFA: sequential organ failure assessment score; APACHE: acute physiology and chronic health evaluation; SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glutamic-pyruvic transaminase; CPR: cardiopulmonary resuscitation. *indicates significant P value <0.05
Figure 1Timing of hospital stay in patients with infectious and noninfectious causes (Kaplan-Meier analysis).